Covalent Molecular Probes for Class A G Protein-Coupled Receptors: Advances and Applications

被引:51
|
作者
Weichert, Dietmar [1 ]
Gmeiner, Peter [1 ]
机构
[1] Univ Erlangen Nurnberg, Emil Fischer Ctr, Dept Chem & Pharm, Med Chem, D-91052 Erlangen, Germany
关键词
MU-OPIOID RECEPTOR; AFFINITY ACYLATING ANTAGONISTS; CRYSTAL-STRUCTURE; BINDING-SITE; PHARMACOLOGICAL CHARACTERIZATION; IRREVERSIBLE LIGANDS; ACETYLCHOLINE MUSTARD; MUSCARINIC RECEPTORS; ADENOSINE RECEPTOR; MEDIATED PHENOMENA;
D O I
10.1021/acschembio.5b00070
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Covalent modification of G. protein-coupled receptors (GPCRs) by employing specific molecular probes has for decades provided a successful strategy to facilitate the elucidation of the structure and function of this pharmacologically important class of membrane proteins. The ligands typically comprise a pharmacophore that generates affinity for a given GPCR and contain a reactive functionality that may form, a covalent bond With a suitably positioned amino acid residue. Covalent ligands have been successfully applied to circumvent poor affinity of compounds when stable labeling of receptor populations was required, and they have been used in the isolation, purification, and pharmacological characterization of specific subtypes of GPCRs. Recently, structural studies have demonstrated that Covalent molecular probes are effective at stabilizing GPCRs to obtain X-ray crystal structures, thus providing valuable insights for the development of novel therapeutics. Herein, we review covalently binding molecular probes for class A GPCRs with a focus on ligands comprising cross-linking groups that do not require photo activation and further highlight their significant and diverse applications.
引用
收藏
页码:1376 / 1386
页数:11
相关论文
共 50 条
  • [11] Molecular basis of proton sensing by G protein-coupled receptors
    Howard, Matthew K.
    Hoppe, Nicholas
    Huang, Xi-Ping
    Mitrovic, Darko
    Billesbolle, Christian B.
    Macdonald, Christian B.
    Mehrotra, Eshan
    Grimes, Patrick Rockefeller
    Trinidad, Donovan D.
    Delemotte, Lucie
    English, Justin G.
    Coyote-Maestas, Willow
    Manglik, Aashish
    CELL, 2025, 188 (03) : 671 - 687.e20
  • [12] Guidelines for the Synthesis of Small-Molecule Irreversible Probes Targeting G Protein-Coupled Receptors
    Jorg, Manuela
    Scammells, Peter J.
    CHEMMEDCHEM, 2016, 11 (14) : 1488 - 1498
  • [13] Secretin family (Class B) G protein-coupled receptors - from molecular to clinical perspectives
    Poyner, David R.
    Hay, Debbie L.
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 166 (01) : 1 - 3
  • [14] Crystallization of G Protein-Coupled Receptors
    Salom, David
    Padayatti, Pius S.
    Palczewski, Krzysztof
    RECEPTOR-RECEPTOR INTERACTIONS, 2013, 117 : 451 - 468
  • [15] G protein-coupled receptors in rheumatology
    Neumann, Elena
    Khawaja, Kiran
    Mueller-Ladner, Ulf
    NATURE REVIEWS RHEUMATOLOGY, 2014, 10 (07) : 429 - 436
  • [16] Optical control of Class A G protein-coupled receptors with photoswitchable ligands
    Wijtmans, Maikel
    Josimovic, Ivana
    Vischer, Henry F.
    Leurs, Rob
    CURRENT OPINION IN PHARMACOLOGY, 2022, 63
  • [17] Recent Advances of Small Molecular Regulators Targeting G Protein-Coupled Receptors Family for Oncology Immunotherapy
    He, Peng
    Zhou, Wenbo
    Liu, Mingyao
    Chen, Yihua
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (16) : 1464 - 1483
  • [18] Progress in Structure Based Drug Design for G Protein-Coupled Receptors
    Congreve, Miles
    Langmead, Christopher J.
    Mason, Jonathan S.
    Marshall, Fiona H.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (13) : 4283 - 4311
  • [19] G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery
    Zhang, Mingyang
    Chen, Ting
    Lu, Xun
    Lan, Xiaobing
    Chen, Ziqiang
    Lu, Shaoyong
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [20] Chemokine receptors and other G protein-coupled receptors
    Lodowski, David T.
    Palczewski, Krzysztof
    CURRENT OPINION IN HIV AND AIDS, 2009, 4 (02) : 88 - 95